BridgeMD
New treatment option for Chronic Back Pain
Official title MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
ClinicalTrials.gov ID: NCT05220202
What this study is testing
- What it's testing
- The proposed study seeks to evaluate effectiveness, implementation processes, and cost of MOTIVATE among older Veterans with chronic musculoskeletal (MSK) pain and comorbid depressive symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 99
You may be able to join if
- Aged 60 and older
- English- speaking
- Self-reported MSK pain (include cLBP +/- radiating symptoms, OA, fibromyalgia) on most days for the past 3 months that interferes with daily...
- Pain intensity that is 4+/10 on the numerical pain rating scale
- Pain interference threshold 5+ on PEG-3
You likely can't join if
- Aged 59 or less
- No telephone
- Not English speaking
- Unwilling to be assigned by chance to either study arm
- Not interested in participating in a non-pharmacologic program
- Self-reported uncorrected hearing and visual impairments precluding ability to participate in telephone sessions or read pedometer screen
See the full eligibility criteria
- Aged 60 and older
- English- speaking
- Self-reported MSK pain (include cLBP +/- radiating symptoms, OA, fibromyalgia) on most days for the past 3 months that interferes with daily activities
- Pain intensity that is 4+/10 on the numerical pain rating scale
- Pain interference threshold 5+ on PEG-3
- Depressive symptoms, 10+ on PHQ-9
- Capable of participating in home-based activity
- Interested in participating in a non-pharmacologic program
- Aged 59 or less
- No telephone
- Not English speaking
- Unwilling to be assigned by chance to either study arm
- Not interested in participating in a non-pharmacologic program
- Self-reported uncorrected hearing and visual impairments precluding ability to participate in telephone sessions or read pedometer screen
- Significant (moderate or severe) cognitive impairment (3+ errors) on six-item screening exam
- Self-reported dependence on wheelchair, bed-bound, or severe balance impairment or severe OA\ (resulting in inability to participate in physical activity intervention)
- Illness requiring hospitalization within the last 3 months that interferes with a home-based physical activity intervention (e.g., fall, gout attack, stroke, heart attack, heart failure, surgery for blocked arteries)
- Suicidal intent (see suicide screening protocol), uncontrolled psychotic disorder or psychiatric hospitalization within 1 year, or enrolled in active substance use program (confirmed with scripted protocol over...
The study team makes the final eligibility decision.
Where it's taking place
- Dallas, Texas, United States
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dallas, Texas, United States; Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.